Promising treatments are coming: a message to lymphoma and CLL patients
The world is changing and in the next decade cancer treatment is sure to be completely changed. Speaking from the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, George Follows, BMBCh, PhD, FRCP, FRCPath, of Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, gives a positive message to lymphoma and chronic lymphocytic leukemia (CLL) patients. Dr Follows emphasizes the exciting time that this is for research, with novel drugs moving through to licensing and the clinic.
Related videos
5:44
What is the best therapy for a young patient with relapsed/refractory CLL?
Jacqueline Barrientos
1:49
Encouraging patients to ask about clinical trials
Simon Rule
1:55
Developing breast cancer patient support, awareness, and education
Jo Taylor
2:15
Increasing awareness and funding for metastatic breast cancer
Beth Roberts
1:13
The role of the Patvocates Network in promoting patient advocacy
Jan Geissler
